Huang Yu-wen
Huang Yu-wen is the director of the Medical Review and Pharmaceutical Benefits Division at Taiwan's National Health Insurance Administration (NHIA). He was in the news for announcing the expansion of NHI coverage to include cancer immunotherapies, which is expected to benefit thousands of cancer patients in Taiwan by significantly reducing their medical expenses.
Not in the pool (under ¢1).
Recent news mentions
Huang Yu-wen said atropine eyedrops help to prevent myopia worsening in children.
Myopia eyedrop policy expanded - Taipei Times
Taiwan· 2026-07-29
Huang Yu-wen said the expanded criteria are expected to benefit about 775 people.
NHI to expand targeted cancer drug coverageTaiwan· 2025-05-19Huang Yu-wen, director of the administration’s Medical Review and Pharmaceutical Benefits Division, said cancer patients can expect to save about NT$1.71 million to NT$2.47 million in medical expenses each year.
Taiwan to expand NHI coverage to include cancer immunotherapiesTaiwan· 2025-04-24